[Form 4] Biomea Fusion, Inc. Insider Trading Activity
Rainer M. Erdtmann, a director and officer of Biomea Fusion (BMEA), reported multiple late-January 2025 stock transfers and a large option award. On 01/28/2025 he disposed of 40,000 shares and on 01/31/2025 recorded three additional disposals of 10,000 each alongside three indirect acquisitions of 10,000 shares attributed to his children, leaving 643,027 shares held directly following those transactions.
The filing discloses indirect holdings held in Trust 1 (174,614), Trust 2 (1,134,989), Point Sur Investors Fund I, LP (228,470) and Point Sur Investors, LLC (252,320). It also reports a grant of 1,246,989 stock options on 08/11/2025 with a $1.53 exercise price, vesting in 16 quarterly installments beginning 08/08/2025 and fully vesting 08/08/2029, expiring 08/10/2035.
Rainer M. Erdtmann, direttore e dirigente di Biomea Fusion (BMEA), ha segnalato più trasferimenti di azioni alla fine di gennaio 2025 e una consistente assegnazione di opzioni. Il 01/28/2025 ha ceduto 40,000 azioni e il 01/31/2025 ha registrato tre ulteriori cessioni da 10,000 ciascuna insieme a tre acquisizioni indirette da 10,000 azioni attribuite ai suoi figli, mantenendo 643,027 azioni detenute direttamente dopo tali operazioni.
La comunicazione indica partecipazioni indirette in Trust 1 (174,614), Trust 2 (1,134,989), Point Sur Investors Fund I, LP (228,470) e Point Sur Investors, LLC (252,320). Riporta inoltre l'assegnazione di 1,246,989 opzioni azionarie il 08/11/2025 con prezzo di esercizio di $1.53, che maturano in 16 tranche trimestrali a partire dal 08/08/2025, con piena maturazione il 08/08/2029 e scadenza il 08/10/2035.
Rainer M. Erdtmann, director y directivo de Biomea Fusion (BMEA), informó varias transferencias de acciones a finales de enero de 2025 y una importante concesión de opciones. El 01/28/2025 enajenó 40,000 acciones y el 01/31/2025 registró tres cesiones adicionales de 10,000 cada una junto con tres adquisiciones indirectas de 10,000 atribuidas a sus hijos, quedando con 643,027 acciones en propiedad directa tras esas operaciones.
El informe revela participaciones indirectas en Trust 1 (174,614), Trust 2 (1,134,989), Point Sur Investors Fund I, LP (228,470) y Point Sur Investors, LLC (252,320). También informa la concesión de 1,246,989 opciones sobre acciones el 08/11/2025 con precio de ejercicio de $1.53, que se consolidan en 16 cuotas trimestrales a partir del 08/08/2025, con consolidación completa el 08/08/2029 y vencimiento el 08/10/2035.
Rainer M. Erdtmann은 Biomea Fusion(BMEA)의 이사이자 임원으로서 2025년 1월 말 여러 차례의 주식 이전과 대규모 스톡옵션 부여를 신고했습니다. 01/28/2025에 40,000주를 처분했으며 01/31/2025에는 각각 10,000주씩 세 건의 추가 처분과 자녀들에게 귀속된 간접 취득 10,000주 세 건을 기록해, 이들 거래 이후 직접 보유 주식은 643,027주입니다.
신고서에는 Trust 1(174,614), Trust 2(1,134,989), Point Sur Investors Fund I, LP(228,470) 및 Point Sur Investors, LLC(252,320)에 대한 간접 보유가 공개되어 있습니다. 또한 08/11/2025에 행사 가격 $1.53인 1,246,989주의 스톡옵션이 부여되었으며, 이는 08/08/2025부터 16회 분기별 베스팅을 거쳐 08/08/2029에 완전히 베스팅되고 만료일은 08/10/2035입니다.
Rainer M. Erdtmann, directeur et cadre de Biomea Fusion (BMEA), a déclaré plusieurs transferts d'actions fin janvier 2025 ainsi qu'une importante attribution d'options. Le 01/28/2025 il a cédé 40,000 actions et le 01/31/2025 a enregistré trois cessions supplémentaires de 10,000 chacune, accompagnées de trois acquisitions indirectes de 10,000 actions attribuées à ses enfants, conservant 643,027 actions détenues directement après ces transactions.
Le dépôt fait état de participations indirectes détenues dans Trust 1 (174,614), Trust 2 (1,134,989), Point Sur Investors Fund I, LP (228,470) et Point Sur Investors, LLC (252,320). Il signale également l'octroi de 1,246,989 options sur actions le 08/11/2025 au prix d'exercice de $1.53, se vestant en 16 tranches trimestrielles à partir du 08/08/2025, vesting complet le 08/08/2029 et expiration le 08/10/2035.
Rainer M. Erdtmann, ein Direktor und leitender Angestellter von Biomea Fusion (BMEA), meldete mehrere Aktienübertragungen Ende Januar 2025 sowie eine umfangreiche Optionszuteilung. Am 01/28/2025 veräußerte er 40,000 Aktien, und am 01/31/2025 wurden drei weitere Veräußerungen zu je 10,000 sowie drei indirekte Erwerbe zu je 10,000 Aktien, zugeschrieben seinen Kindern, verbucht; nach diesen Transaktionen hielt er direkt 643,027 Aktien.
Die Meldung nennt indirekte Bestände in Trust 1 (174,614), Trust 2 (1,134,989), Point Sur Investors Fund I, LP (228,470) und Point Sur Investors, LLC (252,320). Ferner wird die Gewährung von 1,246,989 Aktienoptionen am 08/11/2025 mit einem Ausübungspreis von $1.53 berichtet, die in 16 vierteljährlichen Tranchen ab 08/08/2025 vesten, vollständig am 08/08/2029 vesten und am 08/10/2035 verfallen.
- Substantial equity award: Grant of 1,246,989 stock options at a $1.53 exercise price with multi-year vesting aligns management incentives with shareholders.
- Detailed indirect holdings disclosed: Footnotes list Trust 1 (174,614), Trust 2 (1,134,989), Point Sur LP (228,470) and Point Sur Investors, LLC (252,320), showing continued indirect ownership.
- Multiple share disposals: Disposition of 40,000 shares on 01/28/2025 and three disposals of 10,000 each on 01/31/2025 reduced direct holdings.
- Potential dilution: The 1,246,989 option award at $1.53 strike could materially increase outstanding shares if exercised.
- Beneficial ownership disclaimers: Reporting person disclaims Section 16 beneficial ownership of shares held in Trust 1 and Trust 2, which may complicate assessments of true control.
Insights
TL;DR: Insider transferred shares to family and disclaims certain trust holdings, while retaining substantial indirect ownership.
The Form 4 shows multiple gift/disposition events in late January 2025 that reduce direct holdings to 643,027 shares. Footnotes explicitly state significant indirect positions held via Trust 1, Trust 2, Point Sur LP and Point Sur Investors, LLC, with explicit disclaimers of Section 16 beneficial ownership for the trust-held shares. For governance and disclosure purposes, the mix of direct disposals and large indirect holdings requires clear investor disclosure; the filing provides the explicit holdings and disclaimers but no additional context on intent.
TL;DR: A large option award was granted, creating long-term incentive but also potential equity dilution.
The reporting person received 1,246,989 stock options on 08/11/2025 at a $1.53 exercise price. The award vests in 16 substantially equal quarterly installments beginning 08/08/2025 and fully vests 08/08/2029, with an expiration date of 08/10/2035. This is a material compensation event: it aligns pay with long-term equity performance but represents a sizable potential issuance of common shares if exercised, which investors should quantify against the company's outstanding share count.
Rainer M. Erdtmann, direttore e dirigente di Biomea Fusion (BMEA), ha segnalato più trasferimenti di azioni alla fine di gennaio 2025 e una consistente assegnazione di opzioni. Il 01/28/2025 ha ceduto 40,000 azioni e il 01/31/2025 ha registrato tre ulteriori cessioni da 10,000 ciascuna insieme a tre acquisizioni indirette da 10,000 azioni attribuite ai suoi figli, mantenendo 643,027 azioni detenute direttamente dopo tali operazioni.
La comunicazione indica partecipazioni indirette in Trust 1 (174,614), Trust 2 (1,134,989), Point Sur Investors Fund I, LP (228,470) e Point Sur Investors, LLC (252,320). Riporta inoltre l'assegnazione di 1,246,989 opzioni azionarie il 08/11/2025 con prezzo di esercizio di $1.53, che maturano in 16 tranche trimestrali a partire dal 08/08/2025, con piena maturazione il 08/08/2029 e scadenza il 08/10/2035.
Rainer M. Erdtmann, director y directivo de Biomea Fusion (BMEA), informó varias transferencias de acciones a finales de enero de 2025 y una importante concesión de opciones. El 01/28/2025 enajenó 40,000 acciones y el 01/31/2025 registró tres cesiones adicionales de 10,000 cada una junto con tres adquisiciones indirectas de 10,000 atribuidas a sus hijos, quedando con 643,027 acciones en propiedad directa tras esas operaciones.
El informe revela participaciones indirectas en Trust 1 (174,614), Trust 2 (1,134,989), Point Sur Investors Fund I, LP (228,470) y Point Sur Investors, LLC (252,320). También informa la concesión de 1,246,989 opciones sobre acciones el 08/11/2025 con precio de ejercicio de $1.53, que se consolidan en 16 cuotas trimestrales a partir del 08/08/2025, con consolidación completa el 08/08/2029 y vencimiento el 08/10/2035.
Rainer M. Erdtmann은 Biomea Fusion(BMEA)의 이사이자 임원으로서 2025년 1월 말 여러 차례의 주식 이전과 대규모 스톡옵션 부여를 신고했습니다. 01/28/2025에 40,000주를 처분했으며 01/31/2025에는 각각 10,000주씩 세 건의 추가 처분과 자녀들에게 귀속된 간접 취득 10,000주 세 건을 기록해, 이들 거래 이후 직접 보유 주식은 643,027주입니다.
신고서에는 Trust 1(174,614), Trust 2(1,134,989), Point Sur Investors Fund I, LP(228,470) 및 Point Sur Investors, LLC(252,320)에 대한 간접 보유가 공개되어 있습니다. 또한 08/11/2025에 행사 가격 $1.53인 1,246,989주의 스톡옵션이 부여되었으며, 이는 08/08/2025부터 16회 분기별 베스팅을 거쳐 08/08/2029에 완전히 베스팅되고 만료일은 08/10/2035입니다.
Rainer M. Erdtmann, directeur et cadre de Biomea Fusion (BMEA), a déclaré plusieurs transferts d'actions fin janvier 2025 ainsi qu'une importante attribution d'options. Le 01/28/2025 il a cédé 40,000 actions et le 01/31/2025 a enregistré trois cessions supplémentaires de 10,000 chacune, accompagnées de trois acquisitions indirectes de 10,000 actions attribuées à ses enfants, conservant 643,027 actions détenues directement après ces transactions.
Le dépôt fait état de participations indirectes détenues dans Trust 1 (174,614), Trust 2 (1,134,989), Point Sur Investors Fund I, LP (228,470) et Point Sur Investors, LLC (252,320). Il signale également l'octroi de 1,246,989 options sur actions le 08/11/2025 au prix d'exercice de $1.53, se vestant en 16 tranches trimestrielles à partir du 08/08/2025, vesting complet le 08/08/2029 et expiration le 08/10/2035.
Rainer M. Erdtmann, ein Direktor und leitender Angestellter von Biomea Fusion (BMEA), meldete mehrere Aktienübertragungen Ende Januar 2025 sowie eine umfangreiche Optionszuteilung. Am 01/28/2025 veräußerte er 40,000 Aktien, und am 01/31/2025 wurden drei weitere Veräußerungen zu je 10,000 sowie drei indirekte Erwerbe zu je 10,000 Aktien, zugeschrieben seinen Kindern, verbucht; nach diesen Transaktionen hielt er direkt 643,027 Aktien.
Die Meldung nennt indirekte Bestände in Trust 1 (174,614), Trust 2 (1,134,989), Point Sur Investors Fund I, LP (228,470) und Point Sur Investors, LLC (252,320). Ferner wird die Gewährung von 1,246,989 Aktienoptionen am 08/11/2025 mit einem Ausübungspreis von $1.53 berichtet, die in 16 vierteljährlichen Tranchen ab 08/08/2025 vesten, vollständig am 08/08/2029 vesten und am 08/10/2035 verfallen.